A newly discovered RNA-based mechanism helps CRISPR systems maintain efficiency by preventing interference, offering insights ...
Researchers have used modified CRISPR to silence the extra chromosome 21 in Down syndrome cells, showing promising ...
Sidra Medicine launches Casgevy in Qatar, the first CRISPR gene therapy for sickle cell and thalassemia, offering a potential ...
Hosted on MSN
CRISPR-Cas12a is changing disease detection
CRISPR-Cas12a technology is emerging as a powerful tool for infectious disease diagnostics, combining precision with speed and portability. New one-pot and amplification-free systems are delivering ...
Sidra Medicine, a member of Qatar Foundation, has been qualified by Vertex Pharmaceuticals as one of a of a limited number of ...
Understanding the source of stress and disease can be difficult, especially if the subject of stress is a fish or even thousands of fish.
DOHA: Sidra Medicine, a member of Qatar Foundation, announced that it has been qualified by Vertex Pharmaceuticals as one of ...
The interdisciplinary collaborative project ALIGN will establish a research framework to systematically address the legal, ethical and societal issues surrounding new genomic techniques (NGT) in plant ...
Researchers created “Sequence Display,” a method that generates millions of protein activity data points, allowing AI models ...
For years, AI drug discovery has been judged on benchmark performance. Now, a set of studies shows what happens when those ...
RNA therapies present significant opportunities in targeting a broad range of diseases through various innovative approaches, including antisense oligonucleotides, siRNAs, mRNA vaccines, and aptamers.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results